Zobrazeno 1 - 10
of 15 003
pro vyhledávání: '"proton pump inhibitor"'
Autor:
Abby Ostronic, Christine Gremillion, Song Zhang, Joerg M. Steiner, M. Katherine Tolbert, Emily N. Gould
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 38, Iss 6, Pp 3235-3241 (2024)
Abstract Background Esomeprazole use is increasing in dogs, but the gastrointestinal adverse events associated with q12h dosing necessitate pharmacodynamic evaluation of a reduced dose and frequency of administration. Objectives To compare the effica
Externí odkaz:
https://doaj.org/article/8fbbf03175ff42f9ba703f4b5eacbd48
Autor:
Laure Esparbes, Emile Escourrou, Jordan Birebent, Louis Buscail, Julie Dupouy, Samuel Durliat, Guillaume Le Cosquer
Publikováno v:
BMC Medical Education, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Despite being cornerstone medications for managing gastrointestinal disorders, proton pump inhibitors (PPI) have raised concerns due to inappropriate prescribing and overutilization, their potential side effects, and interactions
Externí odkaz:
https://doaj.org/article/7a3dae3605504b3794b86131d01aefa9
Autor:
Xiulian Zhang, Zhongfu Wang, Tingting Xu, Lei Wei, Fangying Liu, Chunfang Liu, Li Li, Wei Zhang, Shengliang Zhu
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-25 (2024)
Abstract Objectives To assess the efficacy of the Chinese herbal medication Shugan Hewei formula (SHF) combined with rabeprazole in patients with refractory gastroesophageal reflux disease (rGERD). Method A total of 264 participants were randomly ass
Externí odkaz:
https://doaj.org/article/dfa1ba406f1b4eb8ad2aacf5897a9bc6
Autor:
Fahad I. Alsohaibani, Musthafa C. Peedikayil, Mohammed A. Alzahrani, Nahla A. Azzam, Majid A. Almadi, Evan S. Dellon, Abdulrahman A. Al-Hussaini
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 30, Iss 4, Pp 210-227 (2024)
Eosinophilic esophagitis is an antigen-mediated chronic inflammatory disorder that has risen in incidence and prevalence over the past 2 decades. The clinical presentation is variable and consists of mainly esophageal symptoms such as dysphagia, hear
Externí odkaz:
https://doaj.org/article/c315a80f8c02484cbf4263c037a5497b
Autor:
Ju Hyeon Kim, Soon Jun Hong, Jung-Joon Cha, Subin Lim, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Tae Hoon Ahn, Young-Hoon Jeong, Byeong-Keuk Kim, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Jung-Won Suh, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Hyo-Soo Kim, Moo Hyun Kim, Eun-Seok Shin, Do-Sun Lim
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background Concomitant use of clopidogrel and proton pump inhibitor (PPI) is common, but PPI may reduce the antiplatelet effects of clopidogrel in patients undergoing percutaneous coronary intervention (PCI). We evaluated the impact of PPI u
Externí odkaz:
https://doaj.org/article/cdfb954cb1c04c2ca2bd93d8e03efc3e
Publikováno v:
Clinical and Experimental Gastroenterology, Vol Volume 17, Pp 191-200 (2024)
Jianping Cheng,1 Chanjuan Fan,1 Zhen Li,1 Zhaojing Dong,2 Xiaolin Zhao,1 Yong Cai,1 Haiou Ding,3 Yan Dou,4 Xiaomei Zhang4 1Department of Gastroenterology and Oncology, Civil Aviation General Hospital, Beijing, People’s Republic of China; 2Departmen
Externí odkaz:
https://doaj.org/article/2547d000646440ffae77357896c06f1a
Autor:
JING Guanning, ZOU Ying, ZHUO Xiaoqi, SHI Siyan, SONG Yingliu, YAO Mi, CHI Chunhua, LI Junxia
Publikováno v:
Zhongguo quanke yixue, Vol 27, Iss 19, Pp 2344-2351 (2024)
Background The potential risks of long-term use of proton pump inhibitor (PPI) and the potentially inappropriate medication are gradually being taken into account, and PPI deprescribing has been widely recognised, but the situation of long-term use o
Externí odkaz:
https://doaj.org/article/4b4900bc0a1f4fe78a2a85e4e7752101
Publikováno v:
Journal of Epidemiology and Global Health, Vol 14, Iss 3, Pp 1142-1151 (2024)
Abstract Background Guidelines provide various recommendations for the use of proton pump inhibitors (PPI) to prevent upper gastrointestinal (UGI) bleeding in acute myocardial infarction (MI) treatment with dual antiplatelet therapy (DAPT). We evalua
Externí odkaz:
https://doaj.org/article/28cead72d3844c50a44e550cbdd183b7
Publikováno v:
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, Vol 24, Iss 2, Pp 157-167 (2024)
Objectives Associated factors for the failure of Helicobacter pylori (HP) eradication have been evaluated in many studies; however, the different study population of previous studies prevents us from understanding the comparative risk between factors
Externí odkaz:
https://doaj.org/article/9418389d18c9417d8100b3ac0624b53a